Major Adverse Cardiovascular Events According to Thrombolysis in Myocardial Infarction Flow Grade and Intervention Timing Before Percutaneous Coronary Intervention in Non–ST-Segment Elevation Myocardial Infarction
Restricted accessEditorialFirst published online February, 2022
Major Adverse Cardiovascular Events According to Thrombolysis in Myocardial Infarction Flow Grade and Intervention Timing Before Percutaneous Coronary Intervention in Non–ST-Segment Elevation Myocardial Infarction
PuymiratESimonTCaylaG, et al.Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the fast-mi program (french registry of acute st-elevation or non-st-elevation myocardial infarction) 1995 to 2015. Circulation2017; 136(20): 1908–1919.
2.
ChanMYSunJLNewbyLK, et al.Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation2009; 119(24): 3110–3117.
3.
SongYBHahnJYKimJH, et al.Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention. Am J Cardiol2010; 106(10): 1397–1403.
4.
KimYHHerAYJeongMH, et al.Two-year clinical outcomes according to pre-pci timi flow grade and reperfusion timing in non-stemi after newer-generation drug-eluting stents implantation. Angiology2021; DOI: 10.1177/00033197211012537.
5.
ZeymerUHuberKFuY, et al.Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study. Eur Heart J Acute Cardiovasc Care2012; 1(2): 136–142.
6.
De LucaGBrenerSJMehranR, et al.Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial. Int J Cardiol2013; 167(3): 727–732.
7.
ZhangYGaoCLiuH, et al.Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clin Exp Pharmacol Physiol2013; 40(4): 289–294.
8.
LemesleGLaineMPankertM, et al.Optimal timing of intervention in nste-acs without pre-treatment: the early randomized trial. JACC Cardiovasc Interv2020; 13(8): 907–917.
9.
CaseBCYerasiCWangY, et al.Admissions rate and timing of revascularization in the united states in patients with non-st-elevation myocardial infarction. Am J Cardiol2020; 134: 24–31.
10.
AroraSMatsushitaKQamarAStaceyRBCaugheyMC. Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: the atherosclerosis risk in communities surveillance study. Catheter Cardiovasc Interv2018; 91(2): 253–259.
11.
SimDSJeongMHAhnY, et al.Clinical impact of immediate invasive strategy in patients with non-ST-segment elevation myocardial infarction. Int J Cardiol2016; 221: 937–943.
12.
JobsAMehtaSRMontalescotG, et al.Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials. Lancet2017; 390(10096): 737–746.
13.
D’AscenzoFBiondi-ZoccaiGMorettiC, et al.TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials2012; 33(3): 507–514.
14.
BailleulCAissaouiNCaylaG, et al.Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: results from the FAST-MI 2010 registry. Arch Cardiovasc Dis2018; 111(2): 101–108.
15.
JoostAStiermaierTEitelC, et al.Impact of initial culprit vessel flow on infarct size, microvascular obstruction, and myocardial salvage in acute reperfused st-elevation myocardial infarction. Am J Cardiol2016; 118(9): 1316–1322.
16.
SchaafMJMewtonNRioufolG, et al.Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients. J Cardiol2016; 67(3): 248–253.
